Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer. (CORALLEEN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03248427
Recruitment Status : Completed
First Posted : August 14, 2017
Last Update Posted : March 17, 2021
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
SOLTI Breast Cancer Research Group